世界の野兎病市場2021年-2027年:製品別、技術別、検査別、病原体別、地域別

【英語タイトル】Tularemia Market with COVID-19 Impact Analysis, By Product, By Technology, By Test Type, By Pathogen and By Region – Size, Share, & Forecast from 2021-2027

AnalystView Market Insightsが出版した調査資料(AVEW21JN153)・商品コード:AVEW21JN153
・発行会社(調査会社):AnalystView Market Insights
・発行日:2020年12月
・ページ数:208
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Five User(5名様閲覧)USD4,650 ⇒換算¥688,200見積依頼/購入/質問フォーム
Enterprise User(法人閲覧用)USD5,650 ⇒換算¥836,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Analyst View社の本調査レポートでは、世界の野兎病市場について調査・分析し、市場概要、エグゼクティブサマリー、市場動向、市場調査、新型コロナウイルス感染症の影響、市場状況、種類別(腺性野兎病、中咽頭野兎病、潰瘍性腺性野兎病、空気圧野兎病、その他)分析、診断別(免疫化学、顕微鏡検査、その他)分析、医薬品別(自動車、航空宇宙・防衛、医療、工業、その他)分析、エンドユーザー別(真菌性敗血症、細菌性敗血症、その他)分析、地域別分析、主要企業分析、360度アナリストビューなどの項目を掲載しています。
・市場概要
・エグゼクティブサマリー
・市場動向
・市場調査
・新型コロナウイルス感染症の影響
・市場状況
・世界の野兎病市場規模:種類別(腺性野兎病、中咽頭野兎病、潰瘍性腺性野兎病、空気圧野兎病、その他)
・世界の野兎病市場規模:診断別(免疫化学、顕微鏡検査、その他)
・世界の野兎病市場規模:医薬品別(自動車、航空宇宙・防衛、医療、工業、その他)
・世界の野兎病市場規模:エンドユーザー別(真菌性敗血症、細菌性敗血症、その他)
・世界の野兎病市場規模:地域別
・主要企業分析
・360度アナリストビュー

REPORT HIGHLIGHT
The global Tularemia market was valued at USD 230.8 million in 2020, growing with 6.3% CAGR during the forecast period, 2021-2027.

Tularemia is a kind of infectious disease that is caused by bacteria called Francisella tularensis. Various symptoms of tularemia are shortness of breathing, joints & muscle aches, chest pain, swollen lymph glands in the neck, cough, and headache. Tularemia disease mainly occurs in North America, Europe, and the Asia region.

The tularemia market is anticipated to grow at a significant rate in the next few years, owing to the rising number of developments in novel drugs. According to the data of the European center for disease prevention and control, the number of cases from tularemia is around 800 per year. Antibiotics are generally given to the patients of Tularemia. Treatment for tularemia normally lasts for 10-21 days depending on medication requirement. Tularemia disease is highly contagious and may cause death. Several causes including tick bites and exposure to sick or dead animals are responsible for tularemia. Tularemia is caused by different factors such as eating undercooked meat, airborne infection.
Furthermore, the introduction of novel drugs, the development of therapeutic approaches are boosting the growth of the tularemia market. The rising number of tularemia cases across developing countries is contributing to tularemia treatment. According to CDC data, in 2016, around 230 cases of tularemia were found in the U.S. Thus, lack of safe and effective vaccine availability is hindering the market growth. Moreover, stiff regulations regarding the approval of drugs are also impacting market growth.
According to the CDC data, the mortality for tularemia disease is lower than 2.0% and may go up to 24.0% based on strain. The people working in laboratories of tularemia are at great risk of airborne infection through pathogens. If the tularemia treatment is not carried at right time it may cause other disorders such as enlarged liver, enlarged spleen, infection around the heart, spinal cord. This may result in death.

North America held the largest market share in 2019 owing to the rising prevalence of tularemia. Further, the rising number of R&D activities, rising awareness among people is boosting regional growth. Europe is expected to account for the second-largest marker share due to increasing infection across the European countries. The Asia Pacific is expected to witness considerable growth over the forecast period.
The Tularemia market is moderately competitive in nature with the presence of international and local players. Key players in the industry focus on new product development and strategic collaborations to expand their product portfolio. Several players invest in R&D activities to develop new drugs and remain competitive in the industry.

Key features of the study:
• This proposed research study on Tularemia market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year
• The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Tularemia market
• The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Tularemia market
• Impact of COVID-19 on Tularemia market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Tularemia market post-COVID will also be covered.
• In order to give the users of this report a comprehensive view on the Tularemia market, we have also included competitive landscape and key innovator analysis for the Tularemia market.
• The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user’s attractiveness.
• The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Tularemia market.
• In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Tularemia market on global as well as regional level.
• The global Tularemia market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TULAREMIA MARKET KEY PLAYERS
 Pfizer Inc.
 Zydus Cadila
 GlaxoSmithKline plc
 Apotex Inc.
 Alkem Labs
 Sun Pharmaceutical Industries Ltd.
 Mylan Pharmaceuticals Inc.
 Allergan
 Thermo Fisher Scientific Inc.
 Piramal Enterprises Ltd.
 Bayer AG.
 Cipla Inc.
 Lupin Pharmaceuticals Inc.

GLOBAL TULAREMIA MARKET, BY TYPE
 Glandular Tularemia
 Oropharyngeal Tularemia
 Ulcer Glandular Tularemia
 Pneumatic Tularemia
 Others

GLOBAL TULAREMIA MARKET, BY DIAGNOSIS
 Immunochemistry
 Microscopy
 Others

GLOBAL TULAREMIA MARKET, BY DRUGS
 Gentamycin
 Streptomycin
 Ciprofloxacin
 Doxycycline
 Others

GLOBAL TULAREMIA MARKET, BY END USER
 Hospitals & Clinics
 Research & Academic Centers
 Other

GLOBAL TULAREMIA MARKET, BY REGION
 North America
o The U.S.
o Canada
 Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Rest of Europe
 Asia Pacific
o India
o China
o South Korea
o Japan
o Singapore
o Rest of APAC
 Latin America
o Brazil
o Mexico
o Argentina
o Rest of LATAM
 The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Rest of MEA

❖ レポートの目次 ❖

TABLE OF CONTENT
1. Tularemia Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by Diagnosis
2.1.3. Market Snippet by Drugs
2.1.4. Market Snippet by End User
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. Tularemia Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Tularemia Industry Study
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Tularemia Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Tularemia Market Landscape
6.1. Market Share Analysis, 2019
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. Tularemia Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2020 & 2027 (%)
7.2. Glandular Tularemia
7.3. Oropharyngeal Tularemia
7.4. Ulcer Glandular Tularemia
7.5. Pneumatic Tularemia
7.6. Others
8. Tularemia Market – By Diagnosis
8.1. Overview
8.1.1. Segment Share Analysis, By Diagnosis, 2020 & 2027 (%)
8.2. Immunochemistry
8.3. Microscopy
8.4. Others
9. Tularemia Market – By Drugs
9.1. Overview
9.1.1. Segment Share Analysis, By Drugs, 2020 & 2027 (%)
9.2. Gentamycin
9.3. Streptomycin
9.4. Ciprofloxacin
9.5. Doxycycline
9.6. Others
10. Tularemia Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2020 & 2027 (%)
10.2. Fungal Sepsis
10.3. Bacterial Sepsis
10.4. Other
11. Tularemia Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
11.2. North America
11.2.1. Overview
11.2.2. Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.2.5. North America Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.2.6. North America Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Drugs, 2016 – 2027, (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.3.12. Rest of Europe
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.3.12.3. Rest of the Europe Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.3.12.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.3.12.5. Rest of the Europe Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.3.12.6. Rest of the Europe Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.4.12. Rest of APAC
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.4.12.3. Rest of APAC Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.4.12.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.4.12.5. Rest of APAC Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.4.12.6. Rest of APAC Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.5.11. Rest of LATAM
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.5.11.5. Rest of LATAM Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.5.11.6. Rest of LATAM Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2016 – 2027 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Drugs, 2016 – 2027 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2016 – 2027 (US$ Million)
12. Key Vendor Analysis
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Pfizer Inc.
12.2.2. Zydus Cadila
12.2.3. GlaxoSmithKline plc
12.2.4. Apotex Inc.
12.2.5. Alkem Labs
12.2.6. Sun Pharmaceutical Industries Ltd.
12.2.7. Mylan Pharmaceuticals Inc.
12.2.8. Allergan
12.2.9. Thermo Fisher Scientific Inc.
12.2.10. Piramal Enterprises Ltd.
12.2.11. Bayer AG.
12.2.12. Cipla Inc.
12.2.13. Lupin Pharmaceuticals Inc.
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Tularemia market: Types Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Types
TABLE Global Tularemia market, by Types 2016-2027 (USD Million)
TABLE Tularemia market: Diagnosis Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Diagnosis
TABLE Global Tularemia market, by Diagnosis 2016-2027 (USD Million)
TABLE Tularemia market: Regional snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Tularemia market, by Region 2016-2027 (USD Million)
TABLE North America Tularemia market, by Country, 2016-2027 (USD Million)
TABLE North America Tularemia market, by Types, 2016-2027 (USD Million)
TABLE North America Tularemia market, by Diagnosis, 2016-2027 (USD Million)
TABLE Europe Tularemia market, by Country, 2016-2027 (USD Million)
TABLE Europe Tularemia market, by Types, 2016-2027 (USD Million)
TABLE Europe Tularemia market, by Diagnosis, 2016-2027 (USD Million)
TABLE Asia Pacific Tularemia market, by Country, 2016-2027 (USD Million)
TABLE Asia Pacific Tularemia market, by Types, 2016-2027 (USD Million)
TABLE Asia Pacific Tularemia market, by Diagnosis, 2016-2027 (USD Million)
TABLE Latin America Tularemia market, by Country, 2016-2027 (USD Million)
TABLE Latin America Tularemia market, by Type, 2016-2027 (USD Million)
TABLE Latin America Tularemia market, by Diagnosis, 2016-2027 (USD Million)
TABLE Middle East and Africa Tularemia market, by Country, 2016-2027 (USD Million)
TABLE Middle East and Africa Tularemia market, by Type, 2016-2027 (USD Million)
TABLE Middle East and Africa Tularemia market, by Diagnosis, 2016-2027 (USD Million)




List of Figures
FIGURE Tularemia market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2019
FIGURE Type segment market share analysis, 2020 & 2027
FIGURE Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Diagnosis segment market share analysis, 2020 & 2027
FIGURE Diagnosis segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Regional segment market share analysis, 2020 & 2027
FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE North America Tularemia market share and leading players, 2019
FIGURE Europe Tularemia market share and leading players, 2019
FIGURE Asia Pacific Tularemia market share and leading players, 2019
FIGURE Latin America Tularemia market share and leading players, 2019
FIGURE Middle East and Africa Tularemia market share and leading players, 2019
FIGURE North America market share analysis by country, 2019
FIGURE U.S. Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Canada Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Europe Tularemia market share analysis by country, 2019
FIGURE Germany Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Spain Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Italy Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE UK Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE France Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of the Europe Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Asia Pacific Tularemia market share analysis by country, 2019
FIGURE India Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE China Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Japan Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE South Korea Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Singapore Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of APAC Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Latin America Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Latin America Tularemia market share analysis by country, 2019
FIGURE Brazil Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Mexico Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Argentina Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of LATAM Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Middle East and Africa Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Middle East and Africa Tularemia market share analysis by country, 2019
FIGURE Saudi Arabia Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE United Arab Emirates Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)



★調査レポート[世界の野兎病市場2021年-2027年:製品別、技術別、検査別、病原体別、地域別] (コード:AVEW21JN153)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の野兎病市場2021年-2027年:製品別、技術別、検査別、病原体別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆